netFormulary NHS
NHS Bath and North East Somerset, Swindon and Wiltshire CCG
Royal United Hospitals Bath NHS Foundation Trust
Great Western Hospitals NHS Foundation Trust
Salisbury NHS Foundation Trust
 Formulary Chapter 16: Paediatrics - Full Section


This chapter contains information from BCAP, Microguide and 3T's but a joint finalised version has yet to be agreed. Please use the information presented here in combination with the appropriate local guidelines.

Paediatric Drugs and the Traffic Light System

This guidance applies:

  • only where a drug does not already have a TLS classification
  • only for long-term use of a medicine where the patient would not otherwise visit the initiating clinician or unit at intervals of 60 days or less

Paediatric drugs are frequently used outside the makers Summary of Product Characteristics since many manufacturers fail to conduct the relevant trials needed to secure licensed use in paediatrics. Local guidance has made clear that the BNF for Children is the accepted reference.


Drug Indication 

In BNF-C for indication and dose range

In BNF-C but outside indications or dose range Not in BNF-C

Licensed drug within SPC indications

Amber No Shared Care Protocol (SCP) needed


Off label use of drug   (as per BNF-C definition page 2)

Amber if SCP agreed


Unlicensed drug

Amber if SCP agreed


 RCPCH and NPPG joint position statement -

Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
16.01 Cardiovascular system drugs (4,0)
16.02 Fibrinolytic-drugs (1,0)
16.03 Corticosteriods (2,0)
16.04 Hypnotics (2,0)
16.05 Central Nervous System Stimulants (5,0)
16.06 Control of Epilepsy (3,0)
16.07 Status Epilepticus (3,0)
16.08 Antibiotic guidance for Primary Care (1,0)
16.09 Lyme Disease (3,0)
16.10 Blood Glucose Monitoring (1,0)
16.11 Growth Hormone (2,0)
16.12 Bisphosphonates (1,0)
16.13 Drooling Guidelines (3,0)
16.14 Non-steriodal Anti-Inflammatory (1,0)
16.15 Miscellaneous (8,0)
16.16 (0,0)